Featured series 
Tag: Beth Israel Deaconess Medical Center
-
Nation & World
Exploring roots of hunger, eating behaviors
Synaptic plasticity — the ability of the synaptic connections between the brain’s neurons to change and modify over time — has been shown to be a key to memory formation and the acquisition of new learning behaviors. Now research reveals that the neural circuits controlling hunger and eating behaviors are also controlled by plasticity.
-
Nation & World
Tumor cells can prevent tumor spread
A new study from Harvard-affiliated Beth Israel Deaconess Medical Center finds that a group of little-explored cells in the tumor microenvironment likely serves as an important gatekeeper against cancer progression and metastasis.
-
Nation & World
Rebuilding the brain’s circuitry
Harvard scientists have rebuilt genetically diseased circuitry in a section of the mouse hypothalamus, an area controlling obesity and energy balance, demonstrating that complex and intricately wired circuitry of the brain long considered incapable of cellular repair can be rewired with the right type of neuronal “replacement parts.”
-
Nation & World
Survival strategy of cancer cells
A new study led by a scientific team at Beth Israel Deaconess Medical Center and Harvard Medical School has uncovered another key mechanism that cancer cells use as part of their survival strategy — and once again it seems that they are using an enzyme called PKM2 to their advantage.
-
Nation & World
Surgical precision
In ES 227, “Medical Device Design,” SEAS students are given the opportunity to solve practical problems in a hospital setting, trying out the tools, learning about their use in real-world situations, and, in some cases, even sitting in on surgical procedures.
-
Nation & World
Schermerhorn named distinguished fellow
The Society for Vascular Surgery elected Harvard Medical School professor Marc Schermerhorn as a distinguished fellow.
-
Nation & World
Bone loss study takes flight
When the final mission of NASA’s 30-year Space Shuttle program is launched on Friday (July 8), an animal experiment to test a novel therapy to increase bone mass will be on board. Harvard Medical School Asssistant Professor Mary Bouxsein is among the lead researchers.
-
Nation & World
Increasing odds for survival
A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and is potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Harvard investigators at the Dana-Farber Cancer Institute.
-
Nation & World
One vaccine for two strains?
Harvard Medical School researchers believe that identifying the properties of the herpes viruses found in Africa could open the door to developing a more potent vaccine against an infection now rampant in sub-Saharan Africa.
-
Nation & World
Robert M. Goldwyn
Robert M. Goldwyn graduated from Harvard Medical School and later returned there and became Senior Surgeon at the Peter Bent Brigham and Beth Israel Hospitals.
-
Nation & World
Spotlight on Harvard in Brazil
President Drew Faust is traveling this week to highlight Harvard’s engagement with Latin America. In Brazil, she is reconnecting with alumni, exchanging ideas with the leaders of local universities, and meeting with Brazilian students who have studied alongside Harvard students or with Harvard faculty in Brazil.
-
Nation & World
BIDMC’s Pandolfi to receive cancer research award
Cancer geneticist Pier Paolo Pandolfi at Harvard-affiliated Beth Israel Deaconess Medical Center is the recipient of the 2011 Pezcoller Foundation-AACR International Award for Cancer Research.
-
Nation & World
Checking in, saving lives
Harvard researchers have estimated the likely cost-effectiveness of post-discharge follow-up phone calls to smokers hospitalized with acute heart attacks. In a report in the Archives of Internal Medicine, the researchers suggest that phone calls to these discharged smokers encouraging them to quit would yield significant health and economic gains.
-
Nation & World
Placebos work — even without deception
Patients who were knowingly given placebos for irritable bowel syndrome experienced significant symptom relief when compared with controls.
-
Nation & World
Partial reversal of aging achieved in mice
Harvard scientists at Dana-Farber Cancer Institute say they have for the first time partially reversed age-related degeneration in mice, resulting in new growth of the brain and testes, improved fertility, and the return of a lost cognitive function.
-
Nation & World
Rare find
Researchers at Harvard Medical School and the Harvard School of Dental Medicine have found that by mimicking a rare genetic disorder in a dish they can rewind the internal clock of a mature cell and drive it back into an adult stem-cell stage.
-
Nation & World
Promising therapy for stroke patients
A noninvasive electric stimulation technique administered to both sides of the brain can help stroke patients who have lost motor skills in their hands and arms, according to a new study led by researchers at Beth Israel Deaconess Medical Center.
-
Nation & World
Tracking nanoparticles
Using a real-time imaging system, scientists have tracked a group of near-infrared fluorescent nanoparticles from the airspaces of the lungs into the body and out again, providing a description of the characteristics and behavior of the particles that could be used in developing therapeutic agents to treat pulmonary disease.
-
Nation & World
‘Another set of fingers’
An interdisciplinary group of leading Harvard geneticists and stem cell researchers has found a new genetic aspect of cell reprogramming that may ultimately help in the fine-tuning of induced pluripotent stem cells (iPS) into specific cell types.
-
Nation & World
Screening: Side Effects From Endoscopic Procedures
Instead of relying on doctors’ reports about adverse events, Harvard’s Dr. Daniel Leffler used electronic medical records to track emergency visits and hospital admissions that occurred within two weeks of a colonoscopy or upper-gastrointestinal endoscopy and that appeared to be related to the procedures…
-
Nation & World
Improving a cancer drug
Researchers, led by Harvard Medical School Assistant Professor Shiladitya Sengupta, have devised a way to improve a low-cost, effective cancer drug, cisplatin, whose use has been limited by its toxicity.
-
Nation & World
Coming soon: Harvard garden
Harvard will start gardens for growing food in April, with students taking a lead role.
-
Nation & World
Working the night shift
Volunteers assist with a variety of medical skills, from nursing to orthopedics to medical equipment repair, playing a critical role in the response to the Haitian earthquake.
-
Nation & World
Medical workers gain momentum
Harvard-affiliated doctors report on carnage, rescue operations in quake-ravaged Haiti, as medical teams gain traction.
-
Nation & World
Light worsens migraine headaches
Normal 0 0 1 701 4001 33 8 4913 11.1282 0 0 0 Ask people who suffer from migraine headaches what they do when they’re having attacks, and you’re likely…
-
Nation & World
Want to live well?
Harvard faculty members from a range of fields give tips on how to live healthy.
-
Nation & World
Turning genetic trash to treasure
John Rinn, a researcher at Harvard Medical School, the Beth Israel Deaconess Medical Center, and the Broad Institute, overcame a rocky start in life through a passion for biology and discovered a new category of RNAs.
-
Nation & World
Renowned HMS cardiologist Donald Baim dies at 60
Donald Baim, renowned cardiologist, medical device executive, and former Harvard Medical School professor, died on Nov. 6 at the age of 60.